SanBio Co (TSE:4592) Dividend Payout Ratio : 0.00 (As of Jan. 2024)

View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Dividend Payout Ratio?

SanBio Co's dividend payout ratio for the months ended in Jan. 2024 was 0.00.

The historical rank and industry rank for SanBio Co's Dividend Payout Ratio or its related term are showing as below:

TSE:4592's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-04), the Dividend Yield % of SanBio Co is 0.00%.

SanBio Co's Dividends per Share for the months ended in Jan. 2024 was 円0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

SanBio Co Dividend Payout Ratio Historical Data

The historical data trend for SanBio Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Dividend Payout Ratio Chart

SanBio Co Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Dividend Payout Ratio

Get a 7-Day Free Trial

SanBio Co Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of SanBio Co's Dividend Payout Ratio

For the Biotechnology subindustry, SanBio Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SanBio Co's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where SanBio Co's Dividend Payout Ratio falls into.

SanBio Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

SanBio Co's Dividend Payout Ratio for the fiscal year that ended in Jan. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jan. 2024 )	/	EPS without NRI (A: Jan. 2024 )
	=	0	/	-44.635
	=	N/A

SanBio Co's Dividend Payout Ratio for the quarter that ended in Jan. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jan. 2024 )	/	EPS without NRI (Q: Jan. 2024 )
	=	0	/	-14.118
	=	N/A

SanBio Co (TSE:4592) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

SanBio Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of SanBio Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

SanBio Co (TSE:4592) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

SNBIF:USA

Address

8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044

Website

https://www.sanbio.com

SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines